Patent · US Active

Compounds, compositions and methods

US10131676B2 · kind B2 · utility

2Cited by
40References
33Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 29, 2017
Grant dateNov 20, 2018
Priority date—
Expiry dateSep 29, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D498/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure relates generally to compounds and compositions, and their use as kinase inhibitors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.